| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dipyridamole | adenosine deaminase | small molecule | NA | drugbank , DGIDB | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
0.31 | approved | inhibitor |
| dipyridamole | alpha-1-acid glycoprotein 1 | small molecule | NA | drugbank | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | unknown |
| dipyridamole | camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | small molecule | NA | drugbank , DGIDB | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
1.47 | approved | inhibitor |
| dipyridamole | camp-specific 3',5'-cyclic phosphodiesterase 4a | small molecule | NA | drugbank , DGIDB | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
0.16 | approved | inhibitor |
| dipyridamole | cgmp-specific 3',5'-cyclic phosphodiesterase | small molecule | NA | drugbank , DGIDB | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
0.46 | approved | inhibitor |
| dipyridamole | phosphodiesterase 5a | NA | Successful target | TTD , DGIDB | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
0.46 | approved | inhibitor |
| dipyridamole | phosphodiesterase 5a | NA | Successful target | TTD , DGIDB | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
0.46 | approved | unknown |
| dipyridamole | calcipressin-1 | small molecule | NA | drugbank | Heart Valves[MeSHID:D006351] Angina Pectoris[MeSHID:D000787] Postoperative Complications[MeSHID:D011183] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | unknown |
| click here to return to the previous page | ||||||||